Updated Drug Labeling for Patient Safety Act
USA117th CongressHR-9011| House
| Updated: 9/29/2022
A. Donald McEachin
Democratic Representative
Virginia
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Updated Drug Labeling for Patient Safety Act This bill allows generic drug manufacturers to revise labels with updated safety information that differs from the referenced brand-name drug.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationPrescription drugs
Updated Drug Labeling for Patient Safety Act
USA117th CongressHR-9011| House
| Updated: 9/29/2022
Updated Drug Labeling for Patient Safety Act This bill allows generic drug manufacturers to revise labels with updated safety information that differs from the referenced brand-name drug.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
A. Donald McEachin
Democratic Representative
Virginia
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationPrescription drugs